Orbimed Advisors - CATALYST BIOSCIENCES INC ownership

CATALYST BIOSCIENCES INC's ticker is CBIO and the CUSIP is 14888D208. A total of 33 filers reported holding CATALYST BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of CATALYST BIOSCIENCES INC
ValueSharesWeighting
Q4 2021$1,581,000
-85.8%
1,729,402
-36.2%
0.02%
-83.6%
Q3 2021$11,145,000
+21.5%
2,711,600
+28.0%
0.12%
+31.2%
Q2 2021$9,174,000
-14.1%
2,118,6000.0%0.09%
-7.0%
Q1 2021$10,678,0002,118,6000.10%
Other shareholders
CATALYST BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,635,014$10,830,0004.93%
22NW, LP 1,429,242$5,874,0001.75%
Ghost Tree Capital, LLC 1,000,000$4,110,0001.20%
Sio Capital Management, LLC 623,892$2,564,0000.82%
ACUTA CAPITAL PARTNERS, LLC 365,000$1,500,0000.53%
Nantahala Capital Management 2,432,212$9,996,0000.32%
Parkman Healthcare Partners LLC 133,449$548,0000.14%
Ikarian Capital, LLC 454,346$1,867,0000.13%
Orbimed Advisors 2,711,600$11,145,0000.12%
AlphaCentric Advisors LLC 114,000$469,0000.12%
View complete list of CATALYST BIOSCIENCES INC shareholders